LFCR LIFECORE BIOMEDICAL, INC. \DE\
P/E
--
Forward P/E
8.67
Price/Sales
1.886
Beta
0.979
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Lifecore Biomedical Receives Early Antitrust Clearance for Pending Acquisition
Lifecore Biomedical announced it has satisfied a key condition for its pending acquisition by Lifecore Inc. On November 4, 2026, U.S. federal regulators...
Lifecore Biomedical’s third quarter 2026 revenue dropped 19% while gross margins expanded to 27%
Lifecore Biomedical reported a significant decline in revenue for the third quarter of 2026, totaling $25.3 million compared to $31.1 million in the prior...